Rick McElheny
Corporate Officer/Principal chez CLEARSIDE BIOMEDICAL, INC.
Profil
Rick McElheny is the founder of Vidara Therapeutics Holdings LLC.
He is currently the Vice President of Business Development at Clearside Biomedical, Inc. He was previously the Vice President of Development & Supply at HZNP USA LLC from 2011 to 2015 and the Director of Corporate Development at Meda Pharmaceuticals, Inc. He holds an MBA from New York University and an undergraduate degree from The Pennsylvania State University.
Postes actifs de Rick McElheny
| Sociétés | Poste | Début |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Corporate Officer/Principal | 08/11/2016 |
Anciens postes connus de Rick McElheny
| Sociétés | Poste | Fin |
|---|---|---|
HZNP USA LLC
 HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Corporate Officer/Principal | 01/01/2015 |
Meda Pharmaceuticals, Inc.
 Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01/01/2011 |
| Vidara Therapeutics Holdings LLC | Fondateur | - |
Formation de Rick McElheny
| The Pennsylvania State University | Undergraduate Degree |
| New York University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
HZNP USA LLC
HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Health Technology |
Meda Pharmaceuticals, Inc.
Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Health Technology |
| Vidara Therapeutics Holdings LLC | Miscellaneous |